1.Research progress of therapeutic methods for patent ductus arteriosus
Chinese Journal of cardiovascular Rehabilitation Medicine 2015;24(5):582-585
Patent ductus arteriosus (PDA) is a frequent congenital heart disease .Incidence rate of PDA accounts for 10% ~21% of total incidence rate of congenital heart disease .In recent years ,along with the continuous deepening understanding of anatomical structure and pathology of PDA ,there were a variety of treatment methods ,including drug therapy ,interventional therapy and operation .The present article made a review about indications ,contraindi‐cations ,advantages and disadvantages of above three treatments .
2.Pathogenesis of low back pain induced by chronic compartment syndrome
Orthopedic Journal of China 2006;0(01):-
Objective To discuss pathogenesis of low back pain induced by chronic compartment syndrome. Method Thirty patients who had definite chronic lumboscaral compartment syndrome without other lumbal diseases were choosed respectively to test muscle force of lumbar and abdomen,intra-sacrospinal muscle pressure,blood routine,ESR,CK,CK-MM,LDH and LDHs.All patients received decompressive operation.Skeletal muscle specimens taken from sacrospinal muscle in each operation were possessed for histological and ultrastructuml observation. Result All of enzyme tests were normal.The author could observe the dissolved degeneration of part of sacrospinal muscle fibers,muscle fiber hypertrophy,and a small quantity of inflammatory cell infiltration with a light microscope.Focal solution of muscle fiber,the aggregation of mitochondria around the nucleus,the increase of lipid droplet and lysosome in cyte,and the proliferation and differentiation of muscle satellite cell could be observed with an electron microscope. Conclusion Pathogenesis of chronic lumboscaral compartment syndrome may be as followed.Intra-compartmental pressures increase,causing metabolism disturbance of the tissues under fascia compartment,damaging skeletal muscle chronically,then inflammatory factors are released,which stimulates posterior branch of spinal nerves,and finally induces low back pain.
3. Comparison on pharmacodynamic differences between Simiao Pill with crude Atractylodis Rhizoma and bran stir-baked Atractylodis Rhizoma
Chinese Traditional and Herbal Drugs 2013;44(18):2577-2580
Objective: To study the pharmacodynamic differences between Simiao Pills with crude Atractylodis Rhizoma and bran stir-baked Atractylodis Rhizoma on the treatment of adjuvant arthritis. Methods: Wistar rats were randomly divided into blank control group (normal saline), model control group (normal saline), Tripterygium wilfordii glycosides (TWG) group (9.45 mg/kg), low-and high-dose (1.080 and 4.320 g/kg) Simiao Pills (crude Atractylodis Rhizoma) group, low-and high-dose (1.080 and 4.320 g/kg) Simiao Pills (stir-baked Atractylodis Rhizoma with bran) group. Except the blank control group, the other groups were modeled to adjuvant arthritis with complete Freund's. Paw edema value, spleen and thoracic gland indexes, serum interleukin-1β (IL-1β), and nitric oxide (NO) were observed. Results: Both Simiao Pills with crude Atractylodis Rhizoma and bran stir-baked Atractylodis Rhizoma could inhibit paw edema, decrease spleen index, advance the thoracic gland index, and decrease IL-1β and NO. The Simiao Pills with crude Atractylodis Rhizoma showed better effects. Conclusion: Both Simiao Pills with crude Atractylodis Rhizoma and bran stir-baked Atractylodis Rhizoma show a certain therapeutic effect on adjuvant arthritis, but the crude Atractylodis Rhizoma is in favor of the efficacy of Simiao Pills.
4.Primary leydig cell tumor of epididymis: a case report.
Chinese Journal of Pathology 2005;34(4):247-248
Adult
;
Biomarkers, Tumor
;
metabolism
;
Epididymis
;
metabolism
;
pathology
;
surgery
;
Humans
;
Inhibins
;
metabolism
;
Leydig Cell Tumor
;
metabolism
;
pathology
;
surgery
;
Male
;
Testicular Neoplasms
;
metabolism
;
pathology
;
surgery
;
Vimentin
;
metabolism
6.New concepts for treatment of osteoporosis complicated with fracture
Xinxiang XU ; Jiping WANG ; Yan BAI
Chinese Journal of Orthopaedic Trauma 2004;0(12):-
Osteoporosis complicated with fracture is a common and severe condition. This paper summarizes present advances and new concepts in its treatment. Since the secondary osteoporosis will likely develop after fracture treatment with immobilization, more and more bone mass will get lost in addition to primary osteoporosis. A vicious cycle will be established and influence the fracture healing. Therefore, the key to the treatment is to block the vicious cycle to stop or decrease the bone loss. As a routine measure, to do exercises and weight- bearing activities as early as possible is as important as to take medicines for osteoporosis treatment. Stable internal fixation and prosthetic replacement should be firstly chosen for treatment of most fractures. In drug treatment, calcitonin, bisphosphonate (alendronate), HRT (Livial), vitamins D2 and D3, and calcium are indicated.
7.Left Ventricular Hypertrophy to Heart Failure in Gradually Pressure Afterload Heart of Wistar Rat
Feng XU ; Jing DI ; Shuling BAI
Journal of China Medical University 2001;30(1):9-11
Objective:Our purpose was to establish an ideal chronic pressure-afterload heart failure rat model which has the transition from cardiac hypertrophy to heart failure. Methods: Chronic pressure-afterload heart failure rat model was induced by gradually constricting the ascending aorta of young rats. Young rats were randomly divided into 2 groups: the constricted and sham-operated groups. Clinical manifestation, tail-cuff blood pressure, organ weight, and hemodynamic data were observed at various time after operation. Results: The overall survival rate was 87%. Tail-cuff pressure began to increase in 4 weeks after operation. Left ventricular hypertrophy appeared in 12 weeks and heart failure in 5 months. Conclusion:It's a practical and reproducible model of cardiac hypertrophy that progresses to chronic heart failure.
8.Meta-analysis of disodium cantharidinate injection combined with transcatheter arterial chemoembolization in the treatmemt of hepatocellular carcinoma
Zhong XU ; Hui CAO ; Banjun BAI
Chinese Journal of Biochemical Pharmaceutics 2015;37(5):66-71
Objective To evaluate the efficacy and safety of disodium cantharidinate injection combined with transcatheter arterial chemoembolization(TACE) compared with TCAE alone in the treatment of hepatocellular carcinoma(HCC) by meta-analysis.Methods Databases of Pubmed, CNKI,Wangfang and VIP were searched electronically, and the randomized controlled trials about disodium cantharidinate injection combined with TACE in the treatment of HCC were included.Meta-analyses were conducted after the quality of the included studies was assessed.Results Seven eligible studies that included a total of 562 HCC patients were identified in the present meta-analysis.The combined results showed that disodium cantharidinate injection combined with TACE in the treatment of HCC, compared with TACE alone, could increase effective rate ( RR =1.31, 95%CI 1.10-1.56) and clinical benefit rate (RR =1.20, 95%CI 1.04 -1.39), improve the life quality (RR =1.60, 95%CI 1.26 -2.03) and improved the 1, 2 year survival (RR =1.57 with 95%CI 1.28 -1.93 and RR =2.08 with 95%CI 1.46 -2.97, respectively).Conclusion Meta-analysis indicates that the efficacy of disodium cantharidinate injection combined with TACE is superior to TACE alone for the patients with HCC.
9.Cerebral ischemic postconditioning and its neuroprotective mechanisms
Chengping BAI ; Lixuan ZHAN ; En XU
International Journal of Cerebrovascular Diseases 2010;18(5):368-372
Cerebral ischemic postconditioning (IPO) refers to a series of rapid intermittent interruptions of blood flow in the early phase of reperfusion. It protects brain tissue against ischemia-reperfusion injury. IPO decreases infarct volume and neuron loss by activating protein kinases,blocking apoptosis pathways,inhibiting inflammation and oxidative stress. IPO can be applied after cerebral ischemia,and it has better application prospects in clinical practice. This article reviews IPO and its neuroprotective mechanisms.
10.Risk factors for in-hospital mortality in 4437 valve replacement and establishment of Anzhen risk evaluation system
Tao BAI ; Xu MFNG ; Zhaoguang ZHANG
Chinese Journal of Thoracic and Cardiovascular Surgery 2010;26(1):8-12
Objective Background Predicting risk factors for valve replacements is important both for informed consent of patients and objective review of surgical outcomes. Development of reliable prediction rules requires large data sets with ap-propriate risk factors that are available before surgery. Methods Data were from Belling Anzhen Institute of heart, pulmonary and vascular diseases in the period of January 1993 to December 2004. 4482 heart valve replacement patients were analyzed.There. were 848 aortic valve replacements, 2202 mitral valve replacements and 1387 double valve replacements. Logistic regres-sion was used to examine the relationship between risk factors and in-hospital mortality. Results In the multivariable analysis,5 variables in the aortic model (older age, body area, NYHA class IV, creatin, CPB time) , 8 variables in the mitral model ( NYHA class Ⅳ, congestive heart failure, cardiac/thoracic ratio, FS, etiology, LVESD, CPB time, use of IABP) and 7 var-iables in the double valve model (older age, NYHA class Ⅳ, previous myocarditis, diabetes, CPB time, weight index, previ-ous percutaneous mitral balloon valvotomy ) remained independent predictors of the outcome. The mathematical models were highly significant predictors of the in-hospital mortality, and the results were in general agreement with those of others. The area uoder the receiver operating characteristic curve for the aortic model was 0. 921 [ 95% confidence interval ( CI ), 0. 874 to 0. 967 ], for the mitral model was 0. 859 ( 95% CI, 0. 813 to 0. 905 ) aod for dnuhle model was 0. 868 ( 95% CI, 0. 827 to 0.908). The goodness-of-fit statistic for the aortic model was χ~2 = 1.463, P=0.993, for the mitral model was χ~2 = 8.720,P = 0. 366 and for the double valve model was χ~2 = 8 . 134, P = 0. 420. Conclusion We print results and methods for use in day-to-day practice to calculate patient-specific in-hospital mortality after aortic and mitral valve surgery, by the logistic e-quation for each model or a simple scoring system with a look-up table for mortality rate.